Ilytica
Ilytica provides an AI‑enabled, image‑based digital assay platform that delivers lab‑quality, quantitative biomarker results directly to patients outside traditional labs. The system uses a finger‑stick microsample mixed with nanodetectors, captures thousands of assay images, and applies AI to filter noise and generate precise digital measurements. This enables decentralized care by giving clinicians reliable diagnostic data wherever the patient is located.
- Artificial Intelligence
- Digital Health
- Healthcare Technology
- Medical Devices
Funding
Founders
Product
Problem
Diagnostic testing remains tied to centralized laboratories, creating delays and limiting access as care shifts toward decentralized, patient‑centric settings. Traditional assays provide only a bulk signal, which is vulnerable to errors, noise, and artifacts when performed outside controlled lab environments.
Solution
Ilytica’s platform captures a high‑resolution image of a finger‑stick microsample processed with assay‑specific nanodetectors, then applies AI algorithms to isolate individual assay events and filter out noise. By converting these image‑based signals into quantitative, digital biomarker measurements, the system delivers lab‑grade results at the point of care. The workflow requires only a few microliters of blood, a compact reader, and cloud‑connected software that generates reliable diagnostic data instantly. Clinicians can obtain accurate biomarker information wherever patients are located, supporting timely decision‑making without the need for centralized lab infrastructure.
Target Audience
Primary customers are healthcare providers and diagnostic labs that deliver care in decentralized settings, such as primary care clinics, home health services, and telemedicine platforms, as well as pharmaceutical companies conducting point‑of‑care biomarker studies.
Features
- Finger‑stick microsample (~5 µL) mixed with nanodetector reagents specific to the target biomarker
- High‑resolution imaging of thousands of individual assay events rather than a single bulk readout
- AI‑driven signal processing that separates true biomarker signals from noise, artifacts, and environmental variability
- Quantitative digital output calibrated to laboratory‑grade standards, compatible with existing clinical workflows
- Compact, portable reader device with cloud connectivity for immediate result transmission and integration into electronic health records